ClarIDHy Archives - Medical Conferences

Ivosidenib in second-line improves OS in IDH1-mutant cholangiocarcinoma

Presented By

Dr Andrew Zhu, Harvard Medical School, USA

Trial

Phase 3, ClarIDHy

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:46

Presented By

Dr Ghassan Abou-Alfa, Memorial Sloan-Kettering Cancer Center, New York, USA

Trial

Phase 3, ClarIDHy

Conference

ESMO 2019

Type

Peer-reviewed article

26 November 2019 17:22

site created by:

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com